𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B virus mutations associated with antiviral therapy

✍ Scribed by A. Bartholomeusz; S. Locarnini


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
77 KB
Volume
78
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hepatitis B virus mutations associated w
✍ Thomas F. Baumert; Chun Yang; Peter SchΓΌrmann; Josef KΓΆck; Christian Ziegler; Ca πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 451 KB πŸ‘ 1 views

Hepatitis B virus (HBV) core promoter mutations have been implicated in the pathogenesis of fulminant hepatitis B. Due to the limited availability of primary human hepatocytes, the functional characterization of HBV mutants has been performed predominantly in transformed cells, which may not represe

Modeling complex decay profiles of hepat
✍ Harel Dahari; Emi Shudo; Ruy M. Ribeiro; Alan S. Perelson πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 355 KB

Typically, hepatitis B virus (HBV) decays in patients under therapy in a biphasic manner. However, more complex decay profiles of HBV DNA (e.g., flat partial response, triphasic, and stepwise), for which we have no clear understanding, have also been observed in some treated patients. We recently in

In vitro evaluation of hepatitis B virus
✍ Xiaofeng Xiong; Huiling Yang; Christopher E. Westland; Ruiming Zou; Craig S. Gib πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

Several mutations (V521L, P525L, L528M, T532S, and V555I) in the gene for hepatitis B virus (HBV) polymerase have been identified in HBV isolated from patients that displayed break-through viremia during famciclovir treatment. To determine whether these mutations cause phenotypic resistance to famci